Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseas…
$44.46-2.69%
报价 2026-11-13
市值
$837.2M
EV
$858M
PE (TTM)
2.7x
预期 PE (FY2026)
13.6x
52 周区间距高点 -13.6%
$25.44$51.45
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-13不在筛选范围:industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RIGLRigel Pharmaceuticals, Inc. | $837.2M | -2.7% | +4.5% | 91.4% | 2.7x | 9.1x | 11.1x | |
| OMEROmeros Corporation | $1.27B | -2.8% | +5000.0% | 95.8% | 9.7x | 10.7x | – | |
| CRVSCorvus Pharmaceuticals, Inc. | $897.5M | +0.2% | +100.0% | 0% | – | – | – | |
| FDMT4D Molecular Therapeutics, Inc. | $675.6M | +0.9% | -60.3% | 42% | – | – | – | |
| OLMAOlema Pharmaceuticals, Inc. | $662.3M | +0.5% | – | 0% | – | – | – | |
| PRTAProthena Corporation plc | $419M | -0.9% | – | 95.3% | – | – | – | |
| BCYCBicycle Therapeutics plc | $235.9M | -2.3% | – | 100% | – | – | – | |
| AKBAAkebia Therapeutics, Inc. | $131.7M | -4.8% | -5.1% | 78.9% | – | – | 10.6x | |
| GOSSGossamer Bio, Inc. | $67.1M | -2.4% | -57.8% | 99.6% | – | – | – | |
| 同行中位数 | – | – | -5.1% | 87.1% | 9.7x | 10.7x | 10.6x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。